Revive Therapeutics Ltd.
No trades
No trades
Fundamentals and stats
Operating, investing, and financing activities
Free cash flow for Q3 26 is −158.00 USD. For 2025, it was −593.23 K USD and operating cash flow was −593.22 K USD.
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cash flow from operating activities
Cash flow from investing activities
Cash flow from financing activities
MetricsCurrency: USD
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM